Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Carl Icahn

Corporate boards need to learn how to fight with their CEO

Shiva Rajgopal shares three tips for normalizing conflict.

Fortune

Inside Illumina’s bruising proxy battle with billionaire activist investor Carl Icahn

Illumina’s contentious acquisition of cancer test maker Grail brought billionaire Carl Icahn to the company’s doorstep.

Fortune

EU fines US firm Illumina $475 million for jumping gun on buying cancer-screening company Grail

The European Union has slapped a $475 million fine on U.S. biotech giant Illumina for buying out cancer-screening company Grail without the approval of the 27-nation bloc’s antitrust watchdog

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Corporate raider Carl Icahn recovers $1 billion in his fortune as loan deal with big banks alleviates shortseller assault

The billionaire investor Carl Icahn has been under assault from the short-seller Hindenburg Research, forcing him to renegotiate a key loan deal.

Fortune

Stocks Climb as Bond Yields Fall on Signs of Lower Price Pressures

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.24%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.62%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.06%. Stock indexes Monday settled mixed, with the Nasdaq 100...

Barchart

Dow Jones Gains As Apple Stock Tests Key Level; Carl Icahn Stock Explodes Amid These Moves

The Dow Jones was gaining even as Apple stock and Microsoft stock fell. Carl Icahn stock Icahn Enterprises soared as he shored up the firm.

Investors Business Daily

Musk, Zuckerberg lead a $852 billion surge among world’s richest people

The world’s 500 richest people added $852 billion to their fortunes in the first half of 2023.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Illumina’s Sudden CEO Exit Is Just One of Many Problems Facing DNA Company

The sudden resignation of Francis deSouza raises questions about the firm’s future after its proxy fight with Carl Icahn.

Businessweek

Motorola ditched cell phones and found a lucrative second act, fueling one of tech's biggest turnarounds

The company that invented the cell phone now makes most of its money from security tech—and it’s one of tech’s biggest turnaround stories.

Fortune

How Main Street Investors Can Detect Short Seller Misinformation Campaigns

How to avoid the pitfalls and find a better way to short stocks.

StockNews.com

Bill Ackman says Carl Icahn's investment firm is giving him Archegos vibes

Personal loans secured against the value of Icahn's ownership in his own investment firm could prove highly unstable, the Pershing Square founder warns.

Fortune

Carl Icahn bet on America to fail. Instead he lost $9 billion

A short seller accused the billionaire of covering up his losses by bribing shareholders with a dividend. Now he admits his 'mistake': 'Don't fight the fed'

Fortune

Carl Icahn’s activist play plays into the hands of Lina Khan and EU regulators

Every company with acquisition plans in the U.S. and Europe should be concerned about the FTC partnering with EU regulators to sink the Illumina-Grail deal.

Fortune

The 'karmic quality' of Hindenburg's war on Carl Icahn just took on a new cast. It's not just shorting his stock anymore but his bonds, too.

Weeks ago, Icahn's arch rival Bill Ackman commented on the irony of an activist being pursued by an active campaign.

Fortune

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Carl Icahn Gets a Taste of His Own Medicine with the Icahn Enterprises (IEP) Decline

Billionaire Carl Icahn’s conglomerate Icahn Enterprises got hit again with sharp losses, meaning that an activist investor got a taste of his own medicine.

Investors Business Daily

Stock Market Volatile As Nasdaq Tops Key Level. This IBD 50 Stock Soars 21%.

The Nasdaq cleared its Feb. 2 peak and is at the highest point since Aug. 26.

Investors Business Daily

Dow Jones Closes Lower While Uber Rockets. Carl Icahn Hits Back As Stock Craters On Short-Seller Attack.

The Dow Jones plunged as the latest Fed meeting kicked off. Carl Icahn hit back after Icahn Enterprises stock got slammed. Uber stock soared.

Fortune

Short-seller Hindenburg accuses corporate raider Carl Icahn of a “ponzi-like” corporate setup

Hindenburg claims Icahn’s exchange-listed investment vehicle lures small amateur investors with an excessively generous dividend funded by issuing $1.7 billion in new shares since 2019.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

FTC Orders Biotech Illumina To Unwind Grail Deal Amid Icahn Battle

The FTC ordered Monday that biotech firm Illumina must unwind its $8 billion purchase of the cancer-testing startup Grail. ILMN stock fell on the news.

Investors Business Daily

Illumina Surges As Activist Investor Carl Icahn Attempts To Wrest Control

Activist investor Carl Icahn is fighting for control of Illumina after the acquisition of Grail. In response, ILMN stock surged Monday.

Fortune

The bear market will end early next year and create a 'terrific buying opportunity,’ Morgan Stanley’s Mike Wilson says

Wall Street's top strategist Mike Wilson says there's a buying opportunity on the way, but the path to get there is going to be "really tricky."

Fortune

Carl Icahn says ignore Thursday's rally, we aren't out of a bear market

Billionaire investor Carl Icahn reiterated warnings that a recession is coming and that he is keeping his portfolio at Icahn Enterprises hedged

Benzinga

GameStop Shares Pop Tuesday On A Tweet From Ryan Cohen, Here's Why

Activist investor Ryan Cohen is a person who can move the markets with a tweet.

Benzinga

'It's Game Over': Loop Capital Analyst Warns That Bed Bath & Beyond's Days Are Limited

Bed Bath & Beyond Inc (NASDAQ: BBBY) shares hit 52-week lows on Wednesday after the company reported weak earnings results and announced a CEO transition. One analyst believes the pain is just getting started.

Bangkok Post

Icahn Drops Proxy Fight Over Pig Treatment at Kroger

Carl Icahn is dropping a proxy fight focused on the treatment of pregnant pigs at grocery-chain Kroger Co. after concluding he is likely to lose as he did a similar fight at McDonald's Corp. last month.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.